Management of Aripiprazole-Associated Irritability

Introduction to Aripiprazole and Irritability

• The American Academy of Child and Adolescent Psychiatry recommends risperidone as an alternative FDA-approved option for autism-related irritability, with a demonstrated 69% positive response rate for irritability in autism vs. 12% for placebo 1
• For schizophrenia, consider another atypical antipsychotic with lower risk of irritability, such as olanzapine, risperidone, or quetiapine, though each has its own side effect profile 2

Assessment and Management of Irritability

• When managing irritability associated with aripiprazole, determine if irritability is significantly affecting quality of life or treatment adherence, and rule out other causes of irritability, such as medication interactions or comorbid conditions 1
• Consider the original indication for aripiprazole treatment when deciding on a management strategy, and consider switching to an alternative medication based on the original indication 2

Alternative Medications

• For autism-related irritability, consider alpha-2 agonists like guanfacine or clonidine, which have shown efficacy for irritability in autism 1
• For schizophrenia, consider other atypical antipsychotics with different receptor profiles, such as olanzapine, risperidone, or quetiapine, though each has its own side effect profile 2

Monitoring and Precautions

• When switching medications, carefully monitor for withdrawal symptoms from aripiprazole, emergence of new side effects from the alternative medication, and return of original symptoms being treated 2
• Avoid abrupt discontinuation of aripiprazole and taper slowly to prevent withdrawal symptoms, and avoid polypharmacy without clear rationale to prevent cascading side effects 2